{"id":"NCT00230178","sponsor":"Sanofi","briefTitle":"Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome","officialTitle":"Evaluation of Single Agent Rasburicase for 5 Days Versus Sequential Treatment With Rasburicase From Day 1 Through 3 Followed by Oral Allopurinol From Day 3 Through 5 (Overlap on Day 3) Versus Single Agent Oral Allopurinol for 5 Days in the Management of Plasma Uric Acid in Adult Patients With Leukemia, Lymphoma, and Solid Tumor Malignancies at Risk for Hyperuricemia and Tumor Lysis Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-04","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2005-09-30","resultsPosted":"2009-12-31","lastUpdate":"2010-01-12"},"enrollment":280,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Tumor Lysis Syndrome","Cancer","Hyperuricemia"],"interventions":[{"type":"DRUG","name":"Rasburicase (SR29142)","otherNames":[]},{"type":"DRUG","name":"Allopurinol","otherNames":[]}],"arms":[{"label":"Arm A","type":"EXPERIMENTAL"},{"label":"Arm B","type":"EXPERIMENTAL"},{"label":"Arm C","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, multi-center, open-label, parallel group study with three arms:\n\n* Rasburicase alone\n* Rasburicase followed by Allopurinol\n* Allopurinol alone\n\nThe primary objective is to compare the adequacy of control of plasma uric acid concentration and the safety profile among the three arms.","primaryOutcome":{"measure":"Plasma Uric Acid Responder","timeFrame":"Day 3 through Day 7","effectByArm":[{"arm":"Rasburicase","deltaMin":80,"sd":null},{"arm":"Rasburicase + Allopurinol","deltaMin":72,"sd":null},{"arm":"Allopurinol","deltaMin":60,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0009"},{"comp":"OG001 vs OG002","p":"0.0632"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":92},"commonTop":["Nausea","Diarrhoea","Pyrexia","Thrombocytopenia","Neutropenia"]}}